» Articles » PMID: 26177862

Concomitant Expression of Far Upstream Element (FUSE) Binding Protein (FBP) Interacting Repressor (FIR) and Its Splice Variants Induce Migration and Invasion of Non-small Cell Lung Cancer (NSCLC) Cells

Abstract

Transcription factors integrate a variety of oncogenic input information, facilitate tumour growth and cell dissemination, and therefore represent promising therapeutic target structures. Because over-expression of DNA-interacting far upstream element binding protein (FBP) supports non-small cell lung cancer (NSCLC) migration, we asked whether its repressor, FBP-interacting repressor (FIR) is functionally inactivated and how FIR might affect NSCLC cell biology. Different FIR splice variants were highly expressed in the majority of NSCLCs, with the highest levels in tumours carrying genomic gains of chromosome 8q24.3, which contained the FIR gene locus. Nuclear FIR expression was significantly enriched at the invasion front of primary NSCLCs, but this did not correlate with tumour cell proliferation. FIR accumulation was associated with worse patient survival and tumour recurrence; in addition, FIR over-expression significantly correlated with lymph node metastasis in squamous cell carcinomas (SCCs). In vitro, we applied newly developed methods and modelling approaches for the quantitative and time-resolved description of the pro-migratory and pro-invasive capacities of SCC cells. siRNA-mediated silencing of all FIR variants significantly reduced the speed and directional movement of tumour cells in all phases of migration. Furthermore, sprouting efficiency and single cell invasiveness were diminished following FIR inhibition. Interestingly, the silencing of FIR isoforms lacking exon 2 (FIR(Δexon2)) alone was sufficient to reduce lateral migration and invasion. In summary, by using scale-spanning data derived from primary human tissues, quantitative cellular analyses and mathematical modelling, we have demonstrated that concomitant over-expression of FIR and its splice variants drives NSCLC migration and dissemination.

Citing Articles

PUF60 Promotes Chemoresistance Through Drug Efflux and Reducing Apoptosis in Gastric Cancer.

Liu Q, Song Y, Su J, Yang S, Lian Q, Wang T Int J Med Sci. 2025; 22(2):269-282.

PMID: 39781520 PMC: 11704696. DOI: 10.7150/ijms.102976.


Facilitation of diabetic wound healing by far upstream element binding protein 1 through augmentation of dermal fibroblast activity.

Ou S, Sima C, Liu Z, Li X, Chen B Acta Diabetol. 2024; 62(3):353-365.

PMID: 39412701 DOI: 10.1007/s00592-024-02360-8.


Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer.

Zhang C, Ni X, Tao C, Zhou Z, Wang F, Gu F Cell Oncol (Dordr). 2023; 47(1):157-174.

PMID: 37632669 PMC: 10899302. DOI: 10.1007/s13402-023-00859-w.


Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins.

Garcia-Cardenas J, Armendariz-Castillo I, Perez-Villa A, Indacochea A, Jacome-Alvarado A, Lopez-Cortes A Biology (Basel). 2022; 11(4).

PMID: 35453681 PMC: 9030152. DOI: 10.3390/biology11040481.


QuickPIV: Efficient 3D particle image velocimetry software applied to quantifying cellular migration during embryogenesis.

Pereyra M, Drusko A, Kramer F, Strobl F, Stelzer E, Matthaus F BMC Bioinformatics. 2021; 22(1):579.

PMID: 34863116 PMC: 8642913. DOI: 10.1186/s12859-021-04474-0.